LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $854,000 | +4.1% | 8,588 | -0.2% | 0.01% | -12.5% |
Q3 2020 | $820,000 | -16.7% | 8,605 | -2.2% | 0.02% | -20.0% |
Q2 2020 | $984,000 | +54.2% | 8,795 | +0.2% | 0.02% | +33.3% |
Q1 2020 | $638,000 | -34.5% | 8,779 | -6.0% | 0.02% | -21.1% |
Q4 2019 | $974,000 | -1.8% | 9,342 | -6.3% | 0.02% | -9.5% |
Q3 2019 | $992,000 | -16.8% | 9,970 | -4.6% | 0.02% | -16.0% |
Q2 2019 | $1,192,000 | -12.8% | 10,446 | -3.9% | 0.02% | -10.7% |
Q1 2019 | $1,367,000 | -9.5% | 10,872 | -2.3% | 0.03% | -26.3% |
Q4 2018 | $1,511,000 | -11.9% | 11,133 | +78.0% | 0.04% | +5.6% |
Q3 2018 | $1,716,000 | +34.5% | 6,253 | +1.6% | 0.04% | +24.1% |
Q2 2018 | $1,276,000 | +32.0% | 6,157 | +5.2% | 0.03% | +26.1% |
Q1 2018 | $967,000 | +28.6% | 5,855 | +6.7% | 0.02% | +35.3% |
Q4 2017 | $752,000 | +4.3% | 5,489 | +3.6% | 0.02% | -5.6% |
Q3 2017 | $721,000 | +26.5% | 5,298 | +12.8% | 0.02% | +28.6% |
Q2 2017 | $570,000 | +21.3% | 4,695 | +5.8% | 0.01% | +16.7% |
Q1 2017 | $470,000 | +11.4% | 4,438 | +6.8% | 0.01% | +9.1% |
Q4 2016 | $422,000 | +5.8% | 4,156 | +6.4% | 0.01% | 0.0% |
Q3 2016 | $399,000 | -9.7% | 3,907 | +5.5% | 0.01% | -15.4% |
Q2 2016 | $442,000 | +28.1% | 3,704 | +14.9% | 0.01% | +18.2% |
Q1 2016 | $345,000 | +8.8% | 3,223 | +10.3% | 0.01% | +10.0% |
Q4 2015 | $317,000 | +39.0% | 2,923 | +9.8% | 0.01% | +25.0% |
Q3 2015 | $228,000 | -8.4% | 2,662 | +7.7% | 0.01% | 0.0% |
Q2 2015 | $249,000 | +36.8% | 2,472 | +4.5% | 0.01% | +33.3% |
Q1 2015 | $182,000 | +45.6% | 2,366 | +0.9% | 0.01% | +500.0% |
Q4 2014 | $125,000 | +12.6% | 2,344 | -0.7% | 0.00% | 0.0% |
Q3 2014 | $111,000 | -31.5% | 2,360 | -9.4% | 0.00% | 0.0% |
Q2 2014 | $162,000 | -4.1% | 2,605 | +3.5% | 0.00% | 0.0% |
Q1 2014 | $169,000 | -1.2% | 2,517 | -22.5% | 0.00% | 0.0% |
Q4 2013 | $171,000 | – | 3,246 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $8,459 | 3.32% |
VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |